Episurf Medical (Nasdaq: EPIS B) announces that the company will participate in the following investor conferences during November and December:
November 14, Vator Global Healthcare Days Wien
November 19, Redeye Life Science Day, Stockholm
November 27, Vator Unicorn Summit, Stockholm
December 4, Vator Global Healthcare Days Tel Aviv
The company will be represented by CEO Pål Ryfors, and in specific presentations by additional members from the company’s management team.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
CisionBlockPro\Cision\FeedItem Object
(
[HtmlCompanyInformation:protected] =>
[HtmlContact:protected] =>
[HtmlTitle:protected] => <h1><strong><span style="font-family:arial,helvetica,sans-serif">Episurf Medical updates about upcoming investor presentations</span></strong></h1>
[HtmlHeader:protected] =>
[HtmlIntro:protected] =>
[Body:protected] => Episurf Medical (Nasdaq: EPIS B) announces that the company will participate in the following investor conferences during November and December:
November 14, Vator Global Healthcare Days Wien
November 19, Redeye Life Science Day, Stockholm
November 27, Vator Unicorn Summit, Stockholm
December 4, Vator Global Healthcare Days Tel Aviv
The company will be represented by CEO Pål Ryfors, and in specific presentations by additional members from the company’s management team.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
[HtmlBody:protected] => <p><span style="font-size:11pt"><span style="font-family:arial,helvetica,sans-serif">Episurf Medical (Nasdaq: EPIS B) announces that the company will participate in the following investor conferences during November and December:</span></span></p>
<p><span style="font-size:11pt"><span style="font-family:arial,helvetica,sans-serif">November 14, Vator Global Healthcare Days Wien</span></span></p>
<p><span style="font-size:11pt"><span style="font-family:arial,helvetica,sans-serif">November 19, Redeye Life Science Day, Stockholm</span></span></p>
<p><span style="font-size:11pt"><span style="font-family:arial,helvetica,sans-serif">November 27, Vator Unicorn Summit, Stockholm</span></span></p>
<p><span style="font-size:11pt"><span style="font-family:arial,helvetica,sans-serif">December 4, Vator Global Healthcare Days Tel Aviv</span></span></p>
<p><span style="font-size:11pt"><span style="font-family:arial,helvetica,sans-serif">The company will be represented by CEO Pål Ryfors, and in specific presentations by additional members from the company’s management team. </span></span></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><strong><span style="font-family:arial,helvetica,sans-serif; font-size:10pt">For more information, please contact:</span></strong></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><span style="font-size:10pt"><span style="font-family:arial,helvetica,sans-serif">Pål Ryfors, CEO, Episurf Medical</span></span><br>
<span style="font-family:arial,helvetica,sans-serif; font-size:10pt">Tel:</span><span style="font-size:10pt"><span style="font-family:arial,helvetica,sans-serif">+46 (0) 709 62 36 69</span></span><br>
<span style="font-size:10pt"><span style="font-family:arial,helvetica,sans-serif">Email: </span></span><a href="mailto:pal.ryfors@episurf.com"><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt">pal.ryfors@episurf.com</span></span></a></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><strong><span style="font-size:10pt"><span style="font-family:arial,helvetica,sans-serif">About Episurf Medical</span></span></strong></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><em><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt">Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.</span></span></em></p>
[ServiceCategories:protected] => Array
(
[0] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Twitter
[Name:protected] => Twitter
[Value:protected] => 9341
)
[1] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Facebook
[Name:protected] => Facebook
[Value:protected] => 9307
)
)
[LogoUrl:protected] => https://mb.cision.com/Public/14691/logo/96c29c854b230ac3_org.png
[CompanyInformation:protected] =>
[Contact:protected] =>
[Header:protected] =>
[Keywords:protected] => Array
(
[0] => Episurf Medical
[1] => EpiSurf
[2] => Pål Ryfors
)
[QuickFacts:protected] => Array
(
)
[Categories:protected] => Array
(
)
[Videos:protected] => Array
(
)
[Files:protected] => Array
(
[0] => CisionBlockPro\Cision\File Object
(
[IsMain:protected] => 1
[MediaType:protected] => File
[Url:protected] => https://mb.cision.com/Main/14691/2960290/1140464.pdf
[FileName:protected] => wkr0006.pdf
[Title:protected] => Episurf Medical updates about upcoming investor presentations
[Description:protected] => Episurf Medical updates about upcoming investor presentations
[CreateDate:protected] => 2019-11-13T07:30:25.517Z
[Keywords:protected] => Array
(
)
[Extension:protected] => pdf
)
)
[Quotes:protected] => Array
(
)
[ExternalLinks:protected] => Array
(
)
[EmbeddedItems:protected] => Array
(
)
[Id:protected] => 3477945
[EncryptedId:protected] => 4F5BF874171FAD4E
[IsRegulatory:protected] =>
[PublishDate:protected] => 2019-11-13T07:30:00Z
[LastChangeDate:protected] => 2019-11-13T07:30:25.5Z
[Title:protected] => Episurf Medical updates about upcoming investor presentations
[Intro:protected] =>
[IptcCode:protected] => 04016003
[InformationType:protected] => PRM
[LanguageCode:protected] => en
[CountryCode:protected] => se
[CanonicalUrl:protected] =>
[CisionWireUrl:protected] => https://news.cision.com/episurf/r/episurf-medical-updates-about-upcoming-investor-presentations,c2960290
[LanguageVersions:protected] => Array
(
)
[Images:protected] => Array
(
)
[Tickers:protected] => Array
(
[0] => stdClass Object
(
[Symbol] => EPIS B
[ISIN] => SE0003491562
[PrimaryListing] => 1
[IsShare] => 1
[MarketPlaceSymbol] => STO
[MarketPlaceName] => Stockholmsbörsen
[MarketPlaceBloombergCode] => SS
[MarketPlaceMarketWireCode] => OMX
[MarketPlaceIsRegulated] => 1
[MarketPlaceCountryCode] => SE
)
)
)